Table 3.

A comparison of clinical and biochemical data in patients with and without TART (mean ± s.d. or median and range).

	TART (8/25)	No TART (17/25)	P
Age at evaluation (years)	15.3 ± 1.4	15.5 ± 2.7
17OHP (ng/dL) (0.2–2.3)	15.1 ± 3.2	13.2 ± 3.5	NS
Androstenedione (ng/mL) (0.6–2.7)	18.2 ± 3.8	16.3 ± 3.2	NS
Testosterone (nmol/L) (8.5–55.5)	31.0 ± 14.9	27.5 ± 13.2	NS
Height SDS (range)	−1.1 (−0.8/−1.4)	−1.3 (−1.1/−1.6)	NS
BMI SDS (range)	+0.49 (+0.35/+0.55)	+0.41 (+0.22/+0.63)	NS
Age at puberty (years) (range)	11.7 (11.1/12.2)	12.5 (11.5/13.0)	NS